Tests & services
Select disease state
Select modality
The same trusted CGP myeloid results - now delivered faster
Comprehensive genomic profiling (CGP) plays a pivotal role in differentiating disease subtypes and resolving complex diagnostic challenges with greater clarity and confidence than traditional diagnostic testing. Neo Comprehensive® – Myeloid Disorders, a CGP assay, uses DNA and RNA NGS to detect relevant aberrations for diagnostic evaluation, prognosis, risk stratification, and therapy guidance for myeloid disorders with results now available in 8-11 days.
My Compass® test results provided definitive answers both on my diagnosis and my prognosis so that I could spend more time with my family.